Home LiteratureArticle Details
PMID: 7494271 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.

Journal of virology ·Vol. 69 ·No. 12 ·1995-12-00 ·Pages 7630-8

Liu H, Wu X, Newman M, Shaw GM, Hahn BH, Kappes JC

Abstract

The vif gene of human and simian immunodeficiency viruses (HIV and SIV) encodes a late gene product that is essential for viral infectivity in natural target cells. Virions produced in the absence of Vif are abnormal in their ultrastructural morphology and are severely impaired in the ability to complete proviral DNA synthesis upon entry into new target cells. Because previous studies failed to detect Vif protein in virus particles, Vif is believed to influence virus infectivity indirectly, by affecting virion assembly, release, and/or maturation. In this report, we reexamined the possibility that Vif is a virion-associated protein. Utilizing high-titer Vif-specific antibodies, a sensitive immunoblot technique, and highly concentrated virus preparations, we detected a 23-kDa Vif-reactive protein in wild-type HIV type 1 (HIV-1) and a 27-kDa Vif-reactive protein in wild-type SIVSM virions. Neither protein was present in virions derived from vif-deficient HIV-1 and SIVSM proviral constructs. Vif protein content was similar among different strains of HIV-1 and was independent of the cell type (permissive or nonpermissive) used to produce the virus. To determine the subvirion localization of Vif, HIV-1 virions were treated with proteinase K or Triton X-100 to remove virion surface proteins and the viral membrane, respectively, purified through sucrose, and analyzed by immunoblot analysis. Vif protein content was not affected by the removal of external surface proteins or by the removal of the viral membrane and submembrane p17Gag matrix protein. Instead, Vif colocalized with viral core structures which sedimented at a density of 1.25 g/ml on linear sucrose gradients (enveloped HIV-1 particles sediment at a density of 1.17 g/ml). Finally, the amount of Vif protein packaged into virions was estimated to be on the order of 1 molecule of Vif for every 20 to 30 molecules of p24Gag, or between 60 and 100 molecules of Vif per particle. These results indicate that Vif represents an integral component of HIV and SIV particles and raise the possibility that it plays a direct role in early replication events.

MeSH Terms
Amino Acid Sequence Antibodies Base Sequence DNA Primers DNA Replication DNA, Viral/biosynthesis Gene Deletion Gene Products, vif/analysis,biosynthesis Genes, vif HIV/genetics,metabolism HIV-2/genetics,metabolism HeLa Cells Humans Molecular Sequence Data Mutagenesis Peptide Fragments/chemistry,immunology Polymerase Chain Reaction Proviruses/genetics,metabolism Recombinant Proteins/analysis,biosynthesis Simian Immunodeficiency Virus/genetics,metabolism Transfection Virion/genetics,metabolism vif Gene Products, Human Immunodeficiency Virus
Chemicals
Antibodies DNA Primers DNA, Viral Gene Products, vif Peptide Fragments Recombinant Proteins vif Gene Products, Human Immunodeficiency Virus
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Liu H
Department of Medicine, University of Alabama at Birmingham 35294, USA.
Wu X
Newman M
Shaw G M
Hahn B H
Kappes J C
References (44)
44 references, click to expand
  1. Monoclonal antibodies against human immunodeficiency virus (HIV) type 2 core proteins: cross-reactivity with HIV type 1 and simian immunodeficiency virus.
    Proc Natl Acad Sci U S A. 1988 Sep;85(18):6939-43 PMID: 2457921
  2. Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants.
    J Virol. 1995 Jun;69(6):3549-53 PMID: 7745702
  3. Feedback regulation of human immunodeficiency virus type 1 expression by the Rev protein.
    J Virol. 1990 Aug;64(8):3734-41 PMID: 2196381
  4. High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels.
    J Infect Dis. 1991 Jul;164(1):72-80 PMID: 1676046
  5. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes.
    J Virol. 1991 Aug;65(8):3973-85 PMID: 1830110
  6. Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro.
    J Virol. 1991 Aug;65(8):4169-76 PMID: 2072448
  7. Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies.
    J Virol. 1991 Sep;65(9):4832-8 PMID: 1714520
  8. Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: role of the vif gene in HIV-1 infection kinetics and cytopathicity.
    J Virol. 1991 Nov;65(11):5765-73 PMID: 1920615
  9. Conservation of amino-acid sequence motifs in lentivirus Vif proteins.
    Virus Genes. 1992 Jan;6(1):95-102 PMID: 1312756
  10. Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes.
    J Virol. 1995 Jul;69(7):4166-72 PMID: 7769676
  11. HIV accessory proteins: leading roles for the supporting cast.
    Cell. 1995 Jul 28;82(2):189-92 PMID: 7628010
  12. Biological characterization of human immunodeficiency virus type 1 and type 2 mutants in human peripheral blood mononuclear cells.
    Arch Virol. 1992;123(1-2):157-67 PMID: 1550494
  13. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus.
    Virology. 1992 Aug;189(2):695-714 PMID: 1386485
  14. Cell-free transmission of Vif mutants of HIV-1.
    Virology. 1992 Sep;190(1):19-29 PMID: 1529528
  15. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.
    J Virol. 1992 Nov;66(11):6489-95 PMID: 1357189
  16. Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation.
    J Virol. 1992 Nov;66(11):6587-600 PMID: 1404605
  17. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines.
    Science. 1992 Dec 18;258(5090):1935-8 PMID: 1470916
  18. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles.
    J Virol. 1993 Mar;67(3):1663-6 PMID: 8437236
  19. Transcomplementation of VIF- HIV-1 mutants in CEM cells suggests that VIF affects late steps of the viral life cycle.
    Virology. 1993 Mar;193(1):186-92 PMID: 8438565
  20. Early pathogenesis of disease caused by SIVsmmPBj14 molecular clone 1.9 in macaques.
    AIDS Res Hum Retroviruses. 1993 Mar;9(3):277-86 PMID: 8471319
  21. A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes.
    Virology. 1993 Jun;194(2):858-64 PMID: 8503191
  22. Vpx of simian immunodeficiency virus is localized primarily outside the virus core in mature virions.
    J Virol. 1993 Jul;67(7):4386-90 PMID: 8510227
  23. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells.
    J Virol. 1993 Aug;67(8):4945-55 PMID: 8331734
  24. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1.
    J Virol. 1993 Oct;67(10):6322-6 PMID: 8371360
  25. Quantitation of avian RNA tumor virus reverse transcriptase by radioimmunoassay.
    J Virol. 1975 Jul;16(1):146-52 PMID: 48558
  26. A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses.
    Science. 1986 Mar 28;231(4745):1546-9 PMID: 3006243
  27. Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions.
    Science. 1986 Mar 28;231(4745):1549-53 PMID: 3006244
  28. Identification of HTLV-III/LAV sor gene product and detection of antibodies in human sera.
    Science. 1986 Mar 28;231(4745):1553-5 PMID: 3006245
  29. Three novel genes of human T-lymphotropic virus type III: immune reactivity of their products with sera from acquired immune deficiency syndrome patients.
    Proc Natl Acad Sci U S A. 1986 Apr;83(7):2209-13 PMID: 3008154
  30. Genome organization and transactivation of the human immunodeficiency virus type 2.
    Nature. 1987 Apr 16-22;326(6114):662-9 PMID: 3031510
  31. The HIV 'A' (sor) gene product is essential for virus infectivity.
    Nature. 1987 Aug 20-26;328(6132):728-30 PMID: 2441266
  32. The sor gene of HIV-1 is required for efficient virus transmission in vitro.
    Science. 1987 Aug 21;237(4817):888-93 PMID: 3497453
  33. Subcellular localization of the Vif protein of human immunodeficiency virus type 1.
    J Virol. 1994 Feb;68(2):704-12 PMID: 8289374
  34. Role of vif during packing of the core of HIV-1.
    Virology. 1994 Jun;201(2):349-55 PMID: 8184544
  35. Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages.
    J Acquir Immune Defic Syndr. 1994 Sep;7(9):908-15 PMID: 7519673
  36. Growth ability of human immunodeficiency virus type 1 auxiliary gene mutants in primary blood macrophage cultures.
    J Gen Virol. 1994 Sep;75 ( Pt 9):2427-31 PMID: 8077944
  37. Molecular biology of the human immunodeficiency virus accessory proteins.
    J Virol. 1994 Nov;68(11):6831-5 PMID: 7933064
  38. Effects of vif mutations on cell-free infectivity and replication of simian immunodeficiency virus.
    J Acquir Immune Defic Syndr. 1994 Dec;7(12):1228-36 PMID: 7965633
  39. Human immunodeficiency virus-1 reverse transcriptase heterodimer stability.
    Protein Sci. 1994 Sep;3(9):1374-82 PMID: 7530541
  40. Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.
    J Virol. 1995 Apr;69(4):2058-67 PMID: 7884851
  41. Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps.
    J Virol. 1995 Apr;69(4):2068-74 PMID: 7884852
  42. Conservation of an intact human immunodeficiency virus type 1 vif gene in vitro and in vivo.
    J Virol. 1995 Apr;69(4):2557-64 PMID: 7884906
  43. Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.
    J Virol. 1995 Jun;69(6):3389-98 PMID: 7745685
  44. Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14.
    Nature. 1990 Jun 14;345(6276):636-40 PMID: 1971917
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1995-12-00
Pages
7630-8
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC189703
Subset
IM
Grants
NIAID NIH HHS · R01 AI33826 · United States
NIAID NIH HHS · R29 AI31816 · United States
NIAID NIH HHS · U01 AI35282 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]